184
Views
5
CrossRef citations to date
0
Altmetric
Perspective

Colorectal cancer as a complex disease: defining at-risk subjects in the general population – a preventive strategy

, , , , &
Pages 377-385 | Published online: 10 Jan 2014

References

  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. C1161, 759–767 (1990).
  • Lindgren G, Liljegren A, Jaramillo E et al Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 50,228–234 (2002).
  • •Follow-up study in patients undergoing regular preventive colonoscopies for 10 years.
  • Liljegren A, Lindblom A, Rotstein S et al Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut52, 1140–1147 (2003).
  • •Demonstrated a clear correlation between adenoma and hyperplastic polyps in patients under surveillance.
  • Cannon-Albright LA, Skolnick MET, Bishop DT, Lee RG, Burt RVV. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl. I Merl 319 (9), 533–537 (1988).
  • Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E. Familial aggregation of colorectal cancer in the general population. Int. j Cancer68(4), 428–435 (1996).
  • Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl. Merl 331(25), 1669–1674 (1994).
  • Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am. I Gastroenterol 96(10), 2992–3003 (2001).
  • Lovett E. Family studies in cancer of the colon and rectum. BE I Surg. 63(1), 13–18 (1976).
  • St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann. Intern. Merl 118(10), 785–790 (1993).
  • Liljegren A, Lindgren G, Brandberg Y et al Individuals with an increased risk for colorectal cancer — perceived benefit and psychological aspects on surveillance by means of regular colonoscopies. I Clin. Oncol (2004) (In Press).
  • •Demonstrates that patients under surveillance tolerate this preventive strategy.
  • Järvinen HJ, Aamio M, Mustonen H et al Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastmenterology118,829–834 (2000).
  • •Demonstrates the value of preventive colonoscopy programs.
  • Alm T, Licznerski G. The intestinal polyposes. Gun. Gastroenterol 2,577–602 (1973).
  • Björk J, Akerbrant H, Iselius L et al. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. Scam I Gastroenterol 34, 1230–1235 (1999).
  • Olsson L, Lindblom A. Family history of colorectal cancer in a Sweden county. Fain. Cancer 2,87–93 (2003).
  • Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Gardner syndrome in a man with an interstitial deletion of 5q. Aim Merl Genet. 25(3), 473–476 (1986).
  • Bodmer WF, Bailey CJ, Bodmer J et al Localization of the gene for familial adenomatous polyposis on chromosome 5. Natum 328,614–616 (1987).
  • Groden J, Thliveris A, Samowitz W et al. Identification and characterization of thefamilial adenomatous polyposis coli gene. Ce1166, 589–600 (1991).
  • Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 253,661–665 (1991).
  • Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fain. Cancer 2,43–55 (2003).
  • Lynch HT, Krush AJ. Cancer family 'G' revisited: 1895–1970. Cancer 27(6),1505–1511 (1971).
  • Mecldin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 68, 1109–1112 (1991).
  • Aarnio M, Sankila R, Puldcala E et al Cancer risk in mutation carriers of DNA-mismatch-repair genes. int. I Cancer 81, 214–218 (1999).
  • Peltomaki P, Aaltonen LA, Sistonen P et al Genetic mapping of a locus predisposing to human colorectal cancer. Science 260(5109), 810–812 (1993).
  • Lindblom A, Tannergard P, Werelius B, 25Aaltonen LA, Peltomaki P, Leach FS et al Clues to the pathogenesis of familial colorectal cancer. Science 260(5109), 812–816 (1993).
  • Strand M, Prolla TA, Liskay RM et al Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365,274–276 (1993).
  • Fishel R, Lescoe MK, Rao MR et al The human mutator gene homologue MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027–1038 (1993).
  • Leach FS, Nicolaides NC, Papadopoulos N et al Mutations of a mutS homologue inhereditary nonpolyposis colorectal cancer. Ce1175, 1215–1225 (1993).
  • Bronner CE, Baker SM, Morrison PT et al Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature368, 258–261 (1994).
  • Papadopoulos N, Nicolaides NC, Wei YF et al Mutation of a mutL homolog in hereditary colon cancer. Science 263, 1625–1629 (1994).
  • Miyaki M, Konishi M, Tanaka K et al Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genet. 17,271–272 (1997).
  • Huang J, Kuismanen SA, Liu T et al MSH6 and MSH3 are rarely involved in genetic predisposition to non-polypotic colon cancer. Cancer Res. 61,1619–1623 (2001).
  • Liu T, Han H, Kuismanen S et al The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 61(21), 7798–7802 (2001).
  • Liu HX, Zhou XL, Liu T et al The role of hMLH3 in familial colorectal cancer. Cancer Res. 63(8), 1894–1899 (2003).
  • Liu T, Wahlberg S, Burek E et al Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer27, 17–25 (2000).
  • Wiesner GL, Daley D, Lewis S et al A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc. Natl Acad. ScL USA 100,12961–12965 (2003).
  • ••Suggests locus for a predisposing gene.
  • Al-Tassan N, Chmiel NH, Maynard J et al Inherited variants of MYH associated with somatic G:C>TA mutations in colorectal tumors. Natum Genet. 30(2), 227–232 (2002).
  • Lipton L, Halford SE, Johnson V et al Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res. 63(22), 7595–7599 (2003).
  • Sieber OM, Lipton L, Crabtree M et al Multiple colorectal adenomas, classic adenomatous polyposis and germ-line mutations in MYH. N Engl. I Med. 348(9), 791–799 (2003).
  • Vasen HF, Mecklin JP, Khan PM et al The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum 34,424–425 (1991).
  • Meijers-Heijboer H, Wijnen J, Vasen H et al. The CHEK2 1100 deIC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am. Hum. Genet 72,1308–1314 (2003).
  • Lichtenstein P, Holm NV, Verkasalo PK et al Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl. I Med 13,78–85 (2000).
  • Wei EK, Giovannucci E, Wu K et al Comparison of risk factors for colon and rectal cancer. Int. J. Cancer 20,433–442 (2004).
  • Houlston RS, Tomlinson IPM. Polymorphisms and colorectal tumor risk. Gastroenterology 121,282–301 (2001) .
  • •Review of association studies and colorectal cancer.
  • de Jong MM, Note TM, te Meerman GJ et al Low penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers. Prey 11, 1332–1352 (2002).
  • •Review of association studies and colorectal cancer.
  • Keku TO, Millikan RC, Martin C, Rahkra-Burris TK, Sandler RS. Family history of colon cancer — what does it mean and how is it useful? Am J. Prey Med. 24,170–176 (2003).
  • Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic tests in populations. Lancet 357,709–712 (2001).
  • Laken SJ, Papadopoulos N, Petersen GM et al Analysis of masked mutations in familial adenomatous polyposis. Proc. Natl Acad. Sc]. USA 96(5), 2322–2326 (1999).
  • Powell SM, Zilz N, Beazer-Barclay Y et al APC mutations occur early during colorectal tumorigenesis. Nature 359(6392), 235–237 (1992).
  • Laken SJ, Petersen GM, Gruber SB et al Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet. 17(1), 79–83 (1997).
  • Strul H, Barenboim E, Leshno M et al The 11307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews. Cancer Epidemiol Biomarkers. Prey 12,1012–1015 (2003).
  • Moisio AL, Sistonen P, Mecklin JP, Jarvinen H, Peltomaki P. Genetic polymorphisms in carcinogen metabolism and their association to hereditary non-polyposis colon cancer. Gastroenterology 115,1387–1394 (1998).
  • Markowitz S, Wang J, Myeroff L et al Inactivation of the Type II TGF-B receptor in colon cancer cells with microsatellite instability. Science 268,1336–1338 (1995).
  • Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetretrahydrofolate reductase, diets and risk of colon cancer. Cancer Epidemiol Biomarkers. Prev 8,513–518 (1999).
  • •Discussion of the contribution of genes and environment in colorectal cancer risk.
  • Amin NS, Nguyen MN, Scott OH et al Exo1-dependent mutator mutations: model system for studying functional interactions in mismatch repair. Mal Cell Biol. 21, 5142–5155 (2001).
  • Goldstein DB, Weale ME. Population genomics: linkage disequilibrium holds the key. CL117: Bid 11, 576–579 (2001).
  • Reich DE, Cargill M, Bolk S et al Linkage disequilibrium in the human genome. Nature 411,199-204 (2001). Large-scale experiment of 19 randomly selected regions to study linkage disequilibrium for gene mapping.
  • Risch NJ. Searching for genetic determinants in the new millennium. Nature 405,847–856 (2000).
  • ••Review of issues related to postgenomestrategies for unraveling genetic background in complex diseases.
  • Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet358, 1356–1360 (2002).
  • Rish N, Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res. 8,1273–1288 (1998).
  • Ionnidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nature Genet. 29,306–309 (2001).
  • Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 4, 45–61 (2001).
  • Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nature Rev Genet. 33,1–7 (2002).
  • Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet. 11,241–247 (1995).
  • Rish NJ, Merikangas K. The future of genetic studies of complex diseases. Science 273,1516–1517 (1996).
  • Long AD, Langley CH. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res. 9, 720–731 (1999).
  • Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genet. 22, 139–144 (1999).
  • Sachidanandam R, Weissman D, Schmidt SC et al A map of the human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409,928–933 (2001).
  • Daly MJ, Rioux JD, Schaffner SF et al. High-resolution haplotype structure in the human genome. Nature Genet. 29, 229–232 (2001).
  • Johnson GCL, Esposito L, Barratt BJ et al Haplotype tagging for the identification of common disease genes. Nature Genet. 29, 233–237 (2001).
  • Patil N, Berno AJ, Hinds DA et al Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294, 1719–1722 (2001).
  • Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 296,2225-2229 (2002). Suggests that the human genome can be parsed objectively into haplotype blocks.
  • Cargill M, Altshuler D, Ireland J et al Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22,231–238 (1999).
  • Chasman NG, Adams RM. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. I Mol Biol. 307, 683–706 (2001).
  • Dahlman I, Eaves IA, Kosoy R et al Parameters for reliable results in genetic association studies in common disease. Nature Genet. 30, 149–150 (2002).
  • Eaves IA, Merriman RT, Barber RA et al The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nature Genet 25, 320–323 (2000).
  • Glazier AM, Nadeau JH, Altman TJ. Finding genes that underlie complex traits. Science 298, 2345–2349 (2002).
  • Baylin SB, Esteller M, Rountree et al Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mot Genet 10, 687–692 (2001).
  • Chen J, Giovannucci E, Kelsey K et al A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56(21), 4862–4864 (1996).
  • Ma J, Stampfer MJ, Christensen B et al A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyteine and colorectal cancer risk. Cancer Epidemiol Biomarkers Prey. 8, 825–829 (1999).
  • Shannon B, Gnanasampanthan S, Beilby J, Iacopetta B. A polymorphism in the mehylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 50, 520–524 (2002).
  • Keku T, Millikan R, Worley K et al 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and Whites. Cancer Epidemiol Biomarkers Prey 11, 1611–1621 (2002).
  • Hardcastle J, Chamberlain J, Robinson MH et al Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 348, 1472–1477 (1996).
  • Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 348, 1467–1471 (1996).
  • UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer, baseline findings of a UK multicentre randomised trial. Lancet 359(9314), 1291–1300 (2002). Ongoing preventive trial in the general population.
  • Zhou XL, Eriksson U, Werelius B, Kressner U, Sun XF, Lindblom A. Definition of candidate low-risk alleles in a Swedish population. Int. J. Cancer (2004) (In Press).
  • Tannergard P, Lipford JR, Kolodner R, Frödin J E, Nordenskjöld M, Lindblom A. Mutation screening in the hWILH1 gene in Swedish HNPCC families. Cancer Res. 55, 6092–6096 (1995).
  • Liu T, Tannergard P, Hackman P et al Missense mutations in hWILH1 associated with colorectal cancer. Hum. Genet 105, 437–441 (1999).
  • Liu T, Stathopoulos P, Lindblom P et al. MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal susceptibility. hiuj Cancer34, 1981 (1998).
  • Liu T, Chen J, Salahshor S, Kuismannen S et al. Familial endometrial and familial endometrial and colorectal cancer: a separate genetic entity not associated with a defective mismatch repair. J. Med. Genet 38, E29 (2001).
  • Salahshor S, Hou H, Diep CB et al. A germline E-cadherin mutation in a family with familial gastric and colorectal cancer. bit. j Mot Med. 8, 439–443 (2001). Affiliations

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.